Table 2 Demographic and clinical characteristics of 152 patients
From: A case management model for patients with granulomatous mastitis: a prospective study
Variables | Patients (n = 152) |
|---|---|
Age, mean (SD) [range], years | 32 (4) [22–48] |
BMI (kg/m2) | |
≥ 30 | 8 (5.3%) |
25–30 | 64 (42.1%) |
18.5–24.99 | 71 (46.7%) |
< 18.5 | 9 (5.9%) |
Time interval between birth and onset of GLM (years) | |
Pregnancy | 15 (9.9%) |
Breastfeeding | 4 (2.6%) |
Time until last birth (years) (< 2, no breastfeeding) | 26 (17.1%) |
Time until last birth (years) (2–5) | 94 (61.8%) |
Time until last birth (years) (> 5) | 8 (5.3%) |
No birth | 5 (3.3%) |
Comorbid disease | |
Diabetes mellitus | 1 (0.7%) |
Thyroid disease | 1 (0.7%) |
Psychoses | 3 (2.0%) |
Hypertension | 2 (1.3%) |
Hyperprolactinemia | 21 (13.8%) |
Side | |
Left | 81 (53.2%) |
Right | 59 (38.9%) |
Bilateral | 12 (7.9%) |
Sign and symptoms | |
Palpable mass with pain | 150 (98.7%) |
Skin lesion | 114 (75%) |
Abscess | 64 (38.8%) |
Fistula | 8 (5.3%) |
Erythema nodosum | 8 (5.3%) |
Mass size at onset [43] | |
< 1 cm | 6 (4.2%) |
1–2 cm | 40 (26.3%) |
3–5 cm | 69 (45.6%) |
> 5 cm | 36 (23.9%) |
Laboratory tests before treatment | |
C. kroppenstedtii | |
Positive | 36 (23.68%) |
White blood cell (WBC) mean [range], *109/L | 9.77 ± 3.33 (3.59–17.55) |
C-reactive protein (CRP) mean [range], mg/L | 11.91 ± 18.91 (1.0–139) |
Prolactin (PRL) mean [range], ng/mL | 22.70 ± 19.72 (3.5–129.24) |
Types of GM | |
Mass type | 74 (48.7%) |
Abscess type | 66 (43.4%) |
Refractory type | 12 (7.9%) |
Behavior before the onset | |
Breast trauma | 13 (8.6%) |
Excitant food | 22 (14.47%) |
Staying up all night | 12 (7.89%) |